Wednesday October 19, 2016 0 comments
FORT COLLINS -- Symbios Technologies, Inc., a leading developer of dynamic aqueous plasma technology platforms, announced the U.S. Patent and Trademark Office (USPTO) has awarded the company a patent for its tubular high-density plasma reactor, U.S. Patent # 9,346,691.
The Symbios Tubular Plasma Reactor™ (TPR4000™) provides improved, lower-cost oxidation methods for ultrapure, process, and wastewater applications by simultaneously eliminating organic and microbial contamination without the need for added chemicals or producing a waste stream, the company said.
The groundbreaking design of the TPR4000 combines a continuous mixing mechanism with an air-enhanced plasma discharge system.
“This is an important milestone for our company and we are proud of the acknowledgement and protection of our intellectual property provided by this patent award from the USPTO,” said Justin Bzdek, Symbios president and CEO.
“The TPR’s innovative design and impressive economics as an advanced plasma oxidation system for fluid treatment also enables it to be quickly tuned for application in food & beverage, healthcare, power plant, fracking wastewater treatment, and other industrial and municipal markets.”
Symbios said the TPR4000 is the only technology that combines the action and chemistry of UV, ozone, peroxide, and chlorine-based technologies all in one system providing superior efficacy and lower cost vs. alternative advanced oxidation processes.
“This cornerstone patent award is part of an ever expanding portfolio of innovation and patent submissions that highlights our capabilities to address the needs of our industrial partners, with technology made possible by research funded by the National Science Foundation (NSF) Small Business Innovation Research (SBIR) Program,” said Bzdek.